CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 88 filers reported holding CARDIFF ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | 0.0% | 409 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 409 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -66.7% | 409 | -52.4% | 0.00% | – |
| Q3 2021 | $6,000 | 0.0% | 860 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | -25.0% | 860 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | -20.0% | 860 | +53.6% | 0.00% | – |
| Q4 2020 | $10,000 | +11.1% | 560 | -11.8% | 0.00% | – |
| Q3 2020 | $9,000 | +200.0% | 635 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | – | 635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,114,840 | $38,046,000 | 23.72% |
| Corriente Advisors, LLC | 2,000,000 | $35,980,000 | 8.56% |
| Octagon Capital Advisors LP | 650,000 | $11,694,000 | 4.05% |
| Opaleye Management Inc. | 1,662,500 | $29,908,000 | 3.91% |
| Altium Capital Management LP | 185,552 | $3,338,000 | 1.25% |
| Tri Locum Partners LP | 157,403 | $2,832,000 | 1.03% |
| Avidity Partners Management LP | 1,607,000 | $28,910,000 | 0.94% |
| RA Capital Management | 3,290,000 | $59,187,000 | 0.83% |
| FRAZIER MANAGEMENT LLC | 568,500 | $10,227,000 | 0.79% |
| Sio Capital Management, LLC | 149,833 | $2,695,000 | 0.55% |